1075. Phase I Clinical Trial Demonstrates Safety and Feasibility of Autologous Cellular Therapy with Lentiviral Modified CD4 T Cells Expressing Anti-HIV Antisense in Patients with HAART Resistant HIV-1 Infection
2005 ◽
Vol 11
◽
pp. S414-S415
2009 ◽
Vol 27
(50)
◽
pp. 7080-7086
◽
Xia Jin
◽
Mark J. Newman
◽
Stephen De-Rosa
◽
Cristine Cooper
◽
Evan Thomas
◽
...
2006 ◽
Vol 12
(11)
◽
pp. 1150-1160
◽
Daniel H. Fowler
◽
Jeanne Odom
◽
Seth M. Steinberg
◽
Catherine K. Chow
◽
Jason Foley
◽
...
2021 ◽
Vol 32
(1)
◽
pp. 120-121
S. Hiltbrunner
◽
C. Britschgi
◽
P. Schuberth
◽
L. Bankel
◽
T.D.L. Nguyen-Kim
◽
...
2021 ◽
Vol 23
(5)
◽
pp. S196
A. Ekwe
◽
R. Au
◽
B. McEnroe
◽
M. Tan
◽
A. Saldan
◽
...
2013 ◽
Vol 11
(1)
◽
pp. 56-66
Wei Zhu
◽
Guoping Shi
◽
Haijun Tang
◽
Dorothy E. Lewis
◽
Xiao-Tong Song
2019 ◽
Vol 25
(3)
◽
pp. S62
◽
Fenlu Zhu
◽
Nirav N Shah
◽
Dina Schneider
◽
Huiqing Xu
◽
Katherine Chaney
◽
...
2008 ◽
Vol 117
(1)
◽
pp. 35-44
◽
Yuchang Li
◽
Guanhua Li
◽
Anna Ivanova
◽
Sagiv Aaron
◽
Malgorzata Simm
2009 ◽
Vol 17
◽
pp. S112-S113
2006 ◽
Vol 24
(4)
◽
pp. 417-425
◽
Inese Cebere
◽
Lucy Dorrell
◽
Helen McShane
◽
Alison Simmons
◽
Sheena McCormack
◽
...
2015 ◽
Vol 23
◽
pp. S188-S189
◽
Jae H. Park
◽
Isabelle Riviere
◽
Xiuyan Wang
◽
Yvette Bernal
◽
Elizabeth Halton
◽
...
Close
Export Citation Format
Close
Share Document
Close